Qnexa
71
Qnexa - The New Potential Diet Medication
If you suffer from Obesity, you'll know how difficult it can be to stick to a diet, and fit exercise into a busy schedule. Many Americans would love help when it comes to weight loss, and Qnexa could potentially be what they are looking for. This page is all about Qnexa, what is is, what it can do, as well as the side effects it displays. We're not trying to sell it to you, we just want to give you only the fairest information so you can form your own opinions, so sit back, relax, and learn about the brand new medication, still currently in testing, that has got everybody talking.
We Want To Know...
Do you suffer from obesity?
See results without votingHow Qnexa Could Help America
Obesity affects just over 400 million people all around the world. Of this figure, 72 million reside within America. Obesity is continuing to be one of the primary health concerns that effects the adult population in America, as it contributes to a variety of different diseases and conditions, including cardiovascular disease, diabetes, or even hypertension and strokes. Unfortunately, obesity is incredibly preventable, and continues to be the 2nd most preventable death cause within the United States. Believe it or not, obesity not only has an effect on health, but on our economic climate. Currently, obesity accounts for almost $150 billion dollars annually, and if figures don’t improve, by 2030, we can expect a rapid increase of health care costs, adding up to the sum of a staggering $956 billion.
Many American’s are desperate to lose the weight that is often holding them back from living their lives, but they just do not have the help and support available to them. It is because of this that a new treatment by the name of Qnexa was developed. Qnexa is still in its investigational stages, but is believed to potentially be the perfect treatment for obese Americans, allowing to comfortably lose weight and lead a healthier lifestyle. Qnexa is specifically designed to release a special formulation in a controlled way. The formulation is in fact a low dose of Phentermine and Topiramate.
Phentermine and Topiramate have both been approved over the past 50 years – Phentermine in 1959 and Topiramate in 1996. Phentermine has displayed qualities useful for use with weight loss, as it can help lead to weight reduction, improve exercise potential, and help modify behavior and limit calories. Topiramate was actually first approved as a treatment for sufferers of epilepsy, and as a prophylactic for migraine. It was discovered that both of these ingredients combined created a highly effective weight loss treatment.
Qnexa is still being tested and has not yet been approved, but it was very recently involved within a phase 3 trials, which involved over 4,500 obesity sufferers, and was also tested specifically on two people, a man and a woman, on ABC’s Nightline late last year. The female involved dropped 55lbs, decreasing from 232lbs to 177lbs. The male involved lost 73lbs dropping from 343lbs to 270lbs; proving that the medication has positive effects on obesity. Without this medication, the average weight loss was a lot less.
Qnexa has displayed some side effects in a small proportion of testers. Around 15-20% of people involved reported pins and needles, and 12-18% said they had occasional dry mouth. Some, around 6-11%, said they suffered slight constipation and less than 2% reported depression and altered mood. However, half of the participants involved in the experiments were given a placebo drug, and it was found that 1.8% of people taking the placebo also reported depression and altered mood, and 6% also reported similar symptoms of constipation.
As it is still being investigated, Qnexa is not yet available to buy or be prescribed, but it’s likely, once tests are completed, that it will hit the shelves within the next few years. The treatment is taken once a day, and has significantly proved in a range of people that by taking this treatment, you would see significant weight loss, glycemic control as well as a significant improvement in obesity risk factors, such as cardiovascular disease.







